Discovery Genomics opened in 2019 to serve the managed healthcare community by applying a data-driven approach to personalized care. Specifically, our approach to precision medicine is rooted in the integration of both patients and providers. We are accredited by the College of American Pathologists (CAP) and certified as a high-complexity lab under the Clinical Laboratory Improvement Amendments (CLIA).

Discovery Genomics operates within an innovative and ethical business structure, providing insights that will transform the definition of personalized care. We ensure that our clients’ personal information is secure and handled with the utmost respect and care.